As a central regulator of neuroinflammation, NF-κB inhibition can mitigate the excessive inflammatory responses witnessed in AD brains, potentially alleviating the harmful consequences of chronic inflammation on neuronal health. The gene discussed is NFKB1; the disease is Alzheimer disease.